Salivary and serum nitric oxide synthase, macrophage inflammatory protein 1 alpha and macrophage migration inhibitory factor levels in periodontal disease

被引:0
|
作者
Oner, Fatma [1 ]
Onat, Faruk Cagri [2 ]
Karasu, Yerda Ozkan [2 ,3 ]
机构
[1] Bahcesehir Univ, Fac Dent Med, Dept Periodontol, Istanbul, Turkiye
[2] Ataturk Univ, Fac Dent & Med, Dept Periodontol, Erzurum, Turkiye
[3] Ataturk Univ, Fac Dent Med, Dept Periodontol, TR-25200 Yakutiye Erzurum, Turkiye
关键词
Gingivitis; iNOS; MIP-1; alpha; MIF; Periodontitis; PERI-IMPLANT DISEASES; 2017 WORLD WORKSHOP; CONSENSUS REPORT; MIP-1-ALPHA; EXPRESSION; BIOMARKERS; MIF; CLASSIFICATION; CONTRIBUTES; IMMUNITY;
D O I
10.1016/j.heliyon.2024.e25888
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Objective: Periodontal disease is multifactorial inflammatory disease involving both gingivitis and periodontitis. Inducible nitric oxide synthase (iNOS), macrophage inflammatory protein 1 alpha (MIP-1 alpha) and macrophage migration inhibitory factor (MIF) are mediators contributing to the progression of periodontal diseases with distinct functions. The aim of this study is to evaluate the local and systemic iNOS, MIP-1 alpha and MIF concentrations in patients having periodontal disease with different severities. Design: The study was conducted on 88 individuals equally divided into four groups; 1) Periodontally Healthy 2) Gingivitis 3) Stage I-II Periodontitis 4) Stage III-IV Periodontitis. Saliva and serum samples were obtained from each individual and then periodontal examinations were performed. Plaque and bleeding on probing indexes, probing depths and clinical attachment levels were measured on each tooth to determine the periodontal status. Concentrations of iNOS, MIP-1 alpha and MIF were measured with enzyme -linked immunosorbent assay. Results: Patients with stage I-II and stage III-IV periodontitis had more iNOS levels than periodontally healthy people in serum and saliva (p <= 0,001 for serum; p < 0,05 for saliva). Stage III-IV periodontitis group had significantly more serum-iNOS levels than that in gingivitis group (p = 0,005). When compared with periodontally healthy individuals, MIP-1 alpha levels in stage III-IV periodontitis patients were measured significantly more in saliva; (p = 0,016) but less in serum (p = 0,006) samples. More serum-MIF concentrations were observed in stage I-II periodontitis groups than that in periodontally healthy individuals (p < 0,05). Conclusion: Increased salivary and serum iNOS and serum-MIF levels in different stages of periodontitis suggest that these molecules might be involved in periodontal disease pathogenesis. Also, oral microenvironment may stimulate the enhanced MIP-1 alpha concentration in advanced periodontitis cases.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] Parkinson's disease is associated with increased serum levels of macrophage migration inhibitory factor
    Nicoletti, Alessandra
    Fagone, Paolo
    Donzuso, Giulia
    Mangano, Katia
    Dibilio, Valeria
    Caponnetto, Salvatore
    Bendtzen, Klaus
    Zappia, Mario
    Nicoletti, Ferdinando
    CYTOKINE, 2011, 55 (02) : 165 - 167
  • [2] Salivary nitric oxide levels in inflammatory periodontal disease - A case-control and interventional study
    Parwani, S. R.
    Chitnis, P. J.
    Parwani, R. N.
    INTERNATIONAL JOURNAL OF DENTAL HYGIENE, 2012, 10 (01) : 67 - 73
  • [3] Macrophage Migration inhibitory Factor in Clinical Kidney Disease
    Bruchfeld, Annette
    Wendt, Marten
    Miller, Edmund J.
    FRONTIERS IN IMMUNOLOGY, 2016, 7
  • [4] Serum levels of macrophage migration inhibitory factor and interleukin 17 in patients with nonsegmental vitiligo
    Sorour, Osama
    Nassar, Eman
    Eldin Ahmed, Somaya
    Farid, Carmen
    JOURNAL OF EGYPTIAN WOMENS DERMATOLOGICAL SOCIETY, 2020, 17 (01): : 13 - 18
  • [5] Macrophage Migration Inhibitory Factor - A Favorable Marker in Inflammatory Diseases?
    Hertelendy, Johannes
    Reumuth, Georg
    Simons, David
    Stoppe, Christian
    Kim, Bong-Sung
    Stromps, Jan-Philipp
    Fuchs, Paul C.
    Bernhagen, Juergen
    Pallua, Norbert
    Grieb, Gerrit
    CURRENT MEDICINAL CHEMISTRY, 2018, 25 (05) : 601 - 605
  • [6] Impact of Macrophage Migration Inhibitory Factor Gene Polymorphisms and Serum Macrophage Migration Inhibitory Factor Levels on Pulmonary and Spinal Tuberculosis Susceptibility: A Pooled Analysis
    You, Shu-ying
    Zeng, Xiang-bo
    Li, Na
    Yang, Shi-kun
    GENETIC TESTING AND MOLECULAR BIOMARKERS, 2022, 26 (09) : 430 - 442
  • [7] Salivary and serum concentrations of monocyte chemoattractant protein-1, macrophage inhibitory factor, and fractalkine in relation to rheumatoid arthritis and periodontitis
    Yilmaz, Dogukan
    Gonullu, Emel
    Gursoy, Mervi
    Kononen, Eija
    Gursoy, Ulvi Kahraman
    JOURNAL OF PERIODONTOLOGY, 2021, 92 (09) : 1295 - 1305
  • [8] Serum levels of macrophage migration inhibitory factor are associated with rheumatoid arthritis course
    Anais Llamas-Covarrubias, Mara
    Valle, Yeminia
    Elena Navarro-Hernandez, Rosa
    Paola Guzman-Guzman, Iris
    Guadalupe Ramirez-Duenas, Maria
    Rangel-Villalobos, Hector
    Estrada-Chavez, Ciro
    Francisco Munoz-Valle, Jose
    RHEUMATOLOGY INTERNATIONAL, 2012, 32 (08) : 2307 - 2311
  • [9] Elevated levels of serum macrophage migration inhibitory factor in patients with pulmonary tuberculosis
    Yamada, G
    Shijubo, N
    Takagi-Takahashi, Y
    Nishihira, J
    Mizue, Y
    Kikuchi, K
    Abe, S
    CLINICAL IMMUNOLOGY, 2002, 104 (02) : 123 - 127
  • [10] Serum levels of macrophage migration inhibitory factor are associated with rheumatoid arthritis course
    Mara Anaís Llamas-Covarrubias
    Yeminia Valle
    Rosa Elena Navarro-Hernández
    Iris Paola Guzmán-Guzmán
    María Guadalupe Ramírez-Dueñas
    Héctor Rangel-Villalobos
    Ciro Estrada-Chávez
    José Francisco Muñoz-Valle
    Rheumatology International, 2012, 32 : 2307 - 2311